Three-year visual outcomes after brolucizumab in patients with neovascular age-related macular degeneration

被引：0
|
作者：
Yume Kobayashi [1 ]
Maiko Maruyama-Inoue [1 ]
Tatsuya Inoue [1 ]
Yasuo Yanagi [1 ]
Kazuaki Kadonosono [1 ]
机构：
[1] Yokohama City University Medical Center,Department of Ophthalmology
来源：
BMC Ophthalmology | / 25卷 / 1期
关键词：
Age-related macular degeneration; Polypoidal choroidal vasculopathy; Anti-vascular endothelial growth factor; Brolucizumab; Subretinal fluid;
D O I：
10.1186/s12886-025-04049-0
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Three-Year Real World Outcomes of Aflibercept Treatment of Treatment-naive Patients with Neovascular Age-related Macular Degeneration
    Eleftheriadou, Maria
    Gemenetzi, Maria K.
    Sivaprasad, Sobha
    Hykin, Philip G.
    Hamilton, Robin
    Tufail, Adnan
    Patel, Praveen J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [22] Short-term outcomes of switching to brolucizumab in japanese patients with neovascular age-related macular degeneration
    Yoko Kitajima
    Maiko Maruyama-Inoue
    Shoko Ikeda
    Arisa Ito
    Tatsuya Inoue
    Yasuo Yanagi
    Kazuaki Kadonosono
    Japanese Journal of Ophthalmology, 2022, 66 : 511 - 517
  • [23] Short-term outcomes of switching to brolucizumab in japanese patients with neovascular age-related macular degeneration
    Kitajima, Yoko
    Maruyama-Inoue, Maiko
    Ikeda, Shoko
    Ito, Arisa
    Inoue, Tatsuya
    Yanagi, Yasuo
    Kadonosono, Kazuaki
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2022, 66 (06) : 511 - 517
  • [24] Intravitreal Brolucizumab for Neovascular Age-Related Macular Degeneration in a Vitrectomized Eye
    Maggio, Emilia
    Alfano, Alessandro
    Mete, Maurizio
    Pertile, Grazia
    CASE REPORTS IN OPHTHALMOLOGY, 2022, 13 (03): : 736 - 743
  • [25] Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
    Yannuzzi, Nicolas A.
    Freund, K. Bailey
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 1323 - 1329
  • [26] Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
    Enriquez, Ana Bety
    Baumal, Caroline R.
    Crane, Ashley M.
    Witkin, Andre J.
    Lally, David R.
    Liang, Michelle C.
    Enriquez, Jose Ramon
    Eichenbaum, David A.
    JAMA OPHTHALMOLOGY, 2021, 139 (04) : 441 - 448
  • [27] Efficacy of a single injection of brolucizumab in neovascular age-related macular degeneration on visual acuity and micromorphometry
    Joshi, Shrinivas
    Verma, Lalit
    Ayachit, Guruprasad
    Salvi, Rajashree
    Asad, Yusra
    Gupta, Avnindra
    Patil, Anuja
    Ayachit, Apoorva
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2023, 71 (10) : 3375 - 3380
  • [28] The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
    Bae, Ki Woong
    Kim, Dong Ik
    Hwang, Daniel Duck-Jin
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [29] The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
    Ki Woong Bae
    Dong Ik Kim
    Daniel Duck-Jin Hwang
    Scientific Reports, 12
  • [30] Changes in blood flow one year after treatment with aflibercept or brolucizumab for neovascular age-related macular degeneration
    Yamada, Takeyasu
    Osaka, Rie
    Akimitsu, Junichiro
    Kojima, Hirokazu
    Miyoshi, Yukiko
    Yamashita, Ayana
    Nakano, Yuki
    Suzuma, Kiyoshi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
12345